These results suggest that, similarly to the CL subtype of breast cancer, also HGSOC cell lines contain a subpopulation of CD44+/CD24− mesenchymal-like cancer stem cells with highly invasive capacity. The gene discussed is CD44; the disease is breast carcinoma.